chr11-117281395-G-C

Variant summary

Our verdict is Uncertain significance.
0 Uncertain · Cold
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 0 classification points (ACMG Germline Pathogenicity v2019). PM2BP4_Moderate

The NM_207343.4(RNF214):c.1227G>C (p.Lys409Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant has a gnomAD grpmax filtering allele frequency (95% CI) of 0.000000902, indicating it is observed in the general population. Note: a gnomAD entry for this variant shows a statistical allele-bias signature, consistent with mosaic/somatic contamination (e.g. age-related clonal hematopoiesis) rather than true inherited population frequency — this frequency should not be read as evidence of a common, benign germline variant. In-silico predictor (REVEL) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.K409N: Uncertain_significance (ClinVar VariationId 3155290, 1 star)

Frequency

Genomes: not found (cov: 30)
Exomes 𝑓: 0 ( 0 hom. )

Consequence

RNF214
NM_207343.4 missense

Predictors

5
14
REVEL: 0.041 : Benign

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.945

Publications

0 publications found
Genes affected
RNF214 (HGNC:25335): (ring finger protein 214) Predicted to enable ubiquitin-protein transferase activity. [provided by Alliance of Genome Resources, Jul 2025]
BACE1 (HGNC:933): (beta-secretase 1) This gene encodes a member of the peptidase A1 family of aspartic proteases. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature protease. This transmembrane protease catalyzes the first step in the formation of amyloid beta peptide from amyloid precursor protein. Amyloid beta peptides are the main constituent of amyloid beta plaques, which accumulate in the brains of human Alzheimer's disease patients. [provided by RefSeq, Nov 2015]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_207343.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 0 points.

PM2Absent/extremely low in population databases
Very rare in gnomAD for AR/unknown gene (popmax AF < threshold/10) — PM2; GnomAD popmax AF = 0.000000902 — very rare for unknown gene (threshold 0.001) — PM2 moderate.
BP4Computational evidence suggests no impact
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Moderate).

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_207343.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

RNF214 NM_207343.4
MANE Select
HGVSc / HGVSpc.1227G>Cp.Lys409Asn
Exon rankExon 9 of 15
missense
Prot: NP_997226.2
RNF214 NM_001077239.2
HGVSc / HGVSpc.1227G>Cp.Lys409Asn
Exon rankExon 9 of 15
missense
Prot: NP_001070707.1
RNF214 NM_001278249.2
HGVSc / HGVSpc.762G>Cp.Lys254Asn
Exon rankExon 9 of 15
missense
Prot: NP_001265178.1

Ensembl Transcripts

RNF214 ENST00000300650.9
MANE Select
HGVSc / HGVSpc.1227G>Cp.Lys409Asn
Exon rankExon 9 of 15
missense
Prot: ENSP00000300650
RNF214 ENST00000531452.6
TSL:1
HGVSc / HGVSpc.1227G>Cp.Lys409Asn
Exon rankExon 9 of 15
missense
Prot: ENSP00000431643
RNF214 ENST00000852075.2
HGVSc / HGVSpc.1227G>Cp.Lys409Asn
Exon rankExon 9 of 15
missense
Prot: ENSP00000522134

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 3 sources
GnomAD3 genomes
Cov:30
GnomAD4 exome Warning
AF: 6.86e-7
AC:1
Hom:0
AN:1458170
Cov:29
GnomAD4 genome
Cov:30
Showing 3 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
ASC
(Autism)
0.000671 *11490 0.00 *07190
Showing 1 cohortAllele count / allele number. *AF is computed from the counts for ASC (not provided by the source).

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Pathogenic24
AlphaMissense
Uncertain0.38
BayesDel_addAF
Benign-0.14T
BayesDel_noAF
Benign-0.43
CADD
Benign21
DANN
Uncertain1.0
DEOGEN2
Benign0.018T
Eigen
Benign-0.23
Eigen_PC
Benign-0.092
FATHMM_MKL
Benign0.62D
FuncVEP CTI
Benign0.029
GPN-Star LLR
N/A-6.4
GPN-Star score
N/A6.4
LIST_S2
Uncertain0.90D
M_CAP
Benign0.070D
MetaRNN
Benign0.14T
MetaSVM
Benign-0.69T
Mutation Taster
N/A85/15polymorphism
MutationAssessor
Benign0.34N
PhyloP100
Benign0.94
popEVE
Benign-2.9
PrimateAI
Uncertain0.60T
PROVEAN
Benign-0.92N
RBP_binding_hub_radar
N/A0.0
RBP_regulation_power_radar
N/A1.7
REVEL
Benign0.041
Sift
Uncertain0.014D
Sift4G
Benign0.17T
Varity_R
N/A0.11
VESM-3B
Benign-8.2
Showing 30 of 30 scores

Splicing Scores

Pangolin (max)
Benign0.040
SpliceAI score (max)
Benign0.040
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.